# FDA Inspection 1074771 - Vitalant - December 04, 2018

Source: https://www.keypedia.com/records/fda_inspections/vitalant/84fc071c-e831-4ba3-a7ad-5ecb76e26540
Source feed: FDA_Inspections

> FDA Inspection 1074771 for Vitalant on December 04, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1074771
- Company Name: Vitalant
- Inspection Date: 2018-12-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1201540 - 2023-03-02](https://www.keypedia.com/records/fda_inspections/vitalant/7f964935-3d50-474c-beaa-1aa3dd314b20)
- [FDA Inspection 1201540 - 2023-03-02](https://www.keypedia.com/records/fda_inspections/vitalant/e5fe45dc-2f25-43a6-9aa6-c91af665241c)
- [FDA Inspection 1014839 - 2016-11-08](https://www.keypedia.com/records/fda_inspections/vitalant/ac339770-3878-4491-88d0-23347b58d599)
- [FDA Inspection 907184 - 2014-12-16](https://www.keypedia.com/records/fda_inspections/vitalant/28141cfb-8218-420d-bad7-489daeec94bb)
- [FDA Inspection 807329 - 2012-11-14](https://www.keypedia.com/records/fda_inspections/vitalant/8de6babf-b4ac-4ce3-8c13-237fe835cfe4)

Company: https://www.keypedia.com/companies/vitalant/d7a51565-192a-4bc9-84e3-5ff94bb98f7c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d